... developed our protocol based on current recommendations and validated protocols used in other oncological surgery settings. With it, we were able to discharge 80.3% of the patients (90/112) in the ERP group before POD2 in good conditions. The rate of readmission in the ERP group was low (8.04...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Bladder Metastasis Breast cancer Pathology Oncology Breast cancer (BrC) is the most frequently diagnosed malignancy in women according to the latest epidemiology reports, with an estimated...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Qualitiy of life Urologic neoplasms Measurement tools Oncology...

...Michael Froehner; Oliver W. Hakenberg; Manfred P. Wirth During recent years, significant advances have been made in the field of molecular therapy in urologic oncology, mainly for advanced renal cell carcinoma. In this hitherto largely treatment-refractory disease, several agents have been...